Advanced search    

Search: authors:"Yi Wei"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

Copyright © 2017 Yi-Wei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium ... . Conflicts of Interest The authors declare that they have no conflicts of interest. Authors’ Contributions Yi-Wei Xu and Can-Tong Liu contributed equally to this work. Acknowledgments This work was supported

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

Copyright © 2017 Yi-Wei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium ... . Conflicts of Interest The authors declare that they have no conflicts of interest. Authors’ Contributions Yi-Wei Xu and Can-Tong Liu contributed equally to this work. Acknowledgments This work was supported

Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC), one of the most common malignancies worldwide, is a highly aggressive and homogeneous entity occurring in esophageal squamous epithelium, and a reliable noninvasive test for early detection is needed. A recent study showed that serum autoantibodies against Ezrin could be detected in patients with pancreatic cancer. Here, we assessed...

Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC), one of the most common malignancies worldwide, is a highly aggressive and homogeneous entity occurring in esophageal squamous epithelium, and a reliable noninvasive test for early detection is needed. A recent study showed that serum autoantibodies against Ezrin could be detected in patients with pancreatic cancer. Here, we assessed...